Novel permissive murine immunocompetent orthotopic colon carcinoma model for comparison of the antitumoral and safety profiles of three Adv-TKs

Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir

(2010) Iulia Diaconu et al.   JOURNAL OF GENE MEDICINE

Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models

(2009) Fei-qun Zheng et al.   ACTA PHARMACOLOGICA SINICA

Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters

(2009) S Bortolanza et al.   CANCER GENE THERAPY

Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats

(2009) M. Peled et al.   CLINICAL CANCER RESEARCH

A Novel A33 Promoter-Based Conditionally Replicative Adenovirus Suppresses Tumor Growth and Eradicates Hepatic Metastases in Human Colon Cancer Models

(2009) E. G. Cafferata et al.   CLINICAL CANCER RESEARCH

Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters

(2009) Sergia Bortolanza et al.   MOLECULAR THERAPY

ONYX-411, a conditionally replicative oncolytic adenovirus, induces cell death in anaplastic thyroid carcinoma cell lines and suppresses the growth of xenograft tumors in nude mice

(2008) H V Reddi et al.   CANCER GENE THERAPY

Treatment of Cancer with a Novel Dual-Targeted Conditionally Replicative Adenovirus Armed with mda-7/IL-24 Gene

(2008) J. Luo et al.   CLINICAL CANCER RESEARCH

Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters

(2008) D. Dhar et al.   JOURNAL OF VIROLOGY

Biodistribution and kinetics of the novel selective oncolytic adenovirus M1 after systemic administration

(2008) Xiaoyuan Huang et al.   MOLECULAR CANCER THERAPEUTICS